Improvement of nonalcoholic fatty liver disease in ALT at ≥12 months after Roux-en-Y gastric bypass and sleeve gastrectomy, no effect in ALT and AST at < 12 months after SG and in AST at > 12 and ≤24 months after RYGB.

Improvement of nonalcoholic fatty liver disease in ALT at ≥12 months after Roux-en-Y gastric bypass and sleeve gastrectomy, no effect in ALT and AST at <12 months after SG and in AST at >12 and ≤24 months after RYGB. Surg Obes Relat Dis. 2019 Nov 29;: Authors: Wang Y, Chen J, Chen Y, Wu XT PMID: 31899104 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31899104?dopt=Abstract

Source: Surgery for Obesity and Related Diseases : official journal of the American Society for Bariatric Surgery - November 28, 2019 Category: Surgery Authors: Wang Y, Chen J, Chen Y, Wu XT Tags: Surg Obes Relat Dis Source Type: research